Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$6.56 USD
-0.50 (-7.08%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $6.60 +0.04 (0.61%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Actinium Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -48.82 | -33.02 | -24.77 | -22.22 | -21.90 |
Depreciation/Amortization & Depletion | 0.79 | 0.70 | 0.52 | 0.45 | 0.42 |
Net Change from Assets/Liabilities | -3.15 | 38.17 | 1.69 | -1.10 | -1.28 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.84 | 2.80 | 1.69 | 1.25 | 1.29 |
Net Cash From Operating Activities | -47.34 | 8.64 | -20.87 | -21.62 | -21.46 |
Property & Equipment | -0.15 | -0.37 | -0.13 | -0.25 | -0.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.15 | -0.37 | -0.13 | -0.25 | -0.06 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 14.87 | 23.16 | 35.31 | 76.64 | 17.44 |
Issuance (Repayment) of Debt | 0.00 | -0.05 | -0.09 | -0.46 | -0.32 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 14.87 | 23.11 | 35.22 | 76.18 | 17.11 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -32.62 | 31.39 | 14.22 | 54.31 | -4.41 |
Cash at Beginning of Period | 109.61 | 78.22 | 64.00 | 9.69 | 14.10 |
Cash at End of Period | 76.99 | 109.61 | 78.22 | 64.00 | 9.69 |
Diluted Net EPS | -1.83 | -1.37 | -1.20 | -1.83 | -4.50 |
Fiscal Year End for Actinium Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -48.82 | -39.49 | -26.22 | -11.04 |
Depreciation/Amortization & Depletion | NA | 0.79 | 0.59 | 0.39 | 0.18 |
Net Change from Assets/Liabilities | NA | -3.15 | -3.86 | -4.89 | -5.22 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 3.84 | 2.92 | 1.99 | 0.99 |
Net Cash From Operating Activities | NA | -47.34 | -39.85 | -28.72 | -15.08 |
Property & Equipment | NA | -0.15 | -0.15 | -0.12 | -0.08 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.15 | -0.15 | -0.12 | -0.08 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 14.87 | 13.68 | 10.82 | 0.77 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 14.87 | 13.68 | 10.82 | 0.77 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -32.62 | -26.32 | -18.03 | -14.38 |
Cash at Beginning of Period | NA | 109.61 | 109.61 | 109.61 | 109.61 |
Cash at End of Period | NA | 76.99 | 83.29 | 91.58 | 95.23 |
Diluted Net EPS | NA | -0.33 | -0.49 | -0.58 | -0.43 |